Nielsen S, Tse W, Larance B
Cochrane Database Syst Rev. 2022; 9:CD011117.
PMID: 36063082
PMC: 9443668.
DOI: 10.1002/14651858.CD011117.pub3.
Borodovsky J, Levy S, Fishman M, Marsch L
J Addict Med. 2018; 12(3):170-183.
PMID: 29432333
PMC: 5970018.
DOI: 10.1097/ADM.0000000000000388.
Gowing L, Ali R, White J, Mbewe D
Cochrane Database Syst Rev. 2017; 2:CD002025.
PMID: 28220474
PMC: 6464315.
DOI: 10.1002/14651858.CD002025.pub5.
Dunn K, Saulsgiver K, Miller M, Nuzzo P, Sigmon S
Drug Alcohol Depend. 2015; 151:47-55.
PMID: 25823907
PMC: 4447545.
DOI: 10.1016/j.drugalcdep.2015.02.033.
Hussain S, Farhat S, Rather Y, Abbas Z
J Clin Diagn Res. 2015; 9(1):FC01-4.
PMID: 25738001
PMC: 4347092.
DOI: 10.7860/JCDR/2015/10625.5425.
Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes.
Bentzley B, Barth K, Back S, Book S
J Subst Abuse Treat. 2015; 52:48-57.
PMID: 25601365
PMC: 4382404.
DOI: 10.1016/j.jsat.2014.12.011.
Alcohol use disorders negatively influence antiretroviral medication adherence among men who have sex with men in Peru.
Ferro E, Weikum D, Vagenas P, Copenhaver M, Gonzales P, Peinado J
AIDS Care. 2014; 27(1):93-104.
PMID: 25277252
PMC: 4221495.
DOI: 10.1080/09540121.2014.963013.
Utilizing buprenorphine-naloxone to treat illicit and prescription-opioid dependence.
Mauger S, Fraser R, Gill K
Neuropsychiatr Dis Treat. 2014; 10:587-98.
PMID: 24741316
PMC: 3984058.
DOI: 10.2147/NDT.S39692.
Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid-dependents.
Ziaaddini H, Nasirian M, Nakhaee N
Addict Health. 2014; 4(3-4):79-86.
PMID: 24494140
PMC: 3905537.
A comparison of the efficacy of buprenorphine and clonidine in detoxification of heroin-dependents and the following maintenance treatment.
Ziaaddini H, Nasirian M, Nakhaee N
Addict Health. 2014; 2(1-2):18-24.
PMID: 24494096
PMC: 3905506.
A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers.
Sigmon S, Dunn K, Saulsgiver K, Patrick M, Badger G, Heil S
JAMA Psychiatry. 2013; 70(12):1347-54.
PMID: 24153411
PMC: 4131728.
DOI: 10.1001/jamapsychiatry.2013.2216.
Update on the clinical use of buprenorphine: in opioid-related disorders.
Ducharme S, Fraser R, Gill K
Can Fam Physician. 2012; 58(1):37-41.
PMID: 22267618
PMC: 3264008.
The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review.
Dunn K, Sigmon S, Strain E, Heil S, Higgins S
Drug Alcohol Depend. 2011; 119(1-2):1-9.
PMID: 21741781
PMC: 3205338.
DOI: 10.1016/j.drugalcdep.2011.05.033.
From research to the real world: buprenorphine in the decade of the Clinical Trials Network.
Ling W, Jacobs P, Hillhouse M, Hasson A, Thomas C, Freese T
J Subst Abuse Treat. 2010; 38 Suppl 1:S53-60.
PMID: 20307796
PMC: 2853172.
DOI: 10.1016/j.jsat.2010.01.009.
Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy.
Parran T, Adelman C, Merkin B, Pagano M, Defranco R, Ionescu R
Drug Alcohol Depend. 2009; 106(1):56-60.
PMID: 19717249
PMC: 3263699.
DOI: 10.1016/j.drugalcdep.2009.07.013.
Opioid dependence treatment: options in pharmacotherapy.
Stotts A, Dodrill C, Kosten T
Expert Opin Pharmacother. 2009; 10(11):1727-40.
PMID: 19538000
PMC: 2874458.
DOI: 10.1517/14656560903037168.
Buprenorphine for opioid dependence.
Ling W
Expert Rev Neurother. 2009; 9(5):609-16.
PMID: 19402772
PMC: 4151622.
DOI: 10.1586/ern.09.26.
Brief vs. extended buprenorphine detoxification in a community treatment program: engagement and short-term outcomes.
Katz E, Schwartz R, King S, Highfield D, OGrady K, Billings T
Am J Drug Alcohol Abuse. 2009; 35(2):63-7.
PMID: 19199166
PMC: 3140220.
DOI: 10.1080/00952990802585380.
Buprenorphine tapering schedule and illicit opioid use.
Ling W, Hillhouse M, Domier C, Doraimani G, Hunter J, Thomas C
Addiction. 2009; 104(2):256-65.
PMID: 19149822
PMC: 3150159.
DOI: 10.1111/j.1360-0443.2008.02455.x.
Brief buprenorphine detoxification for the treatment of prescription opioid dependence: a pilot study.
Sigmon S, Dunn K, Badger G, Heil S, Higgins S
Addict Behav. 2008; 34(3):304-11.
PMID: 19081679
PMC: 2643343.
DOI: 10.1016/j.addbeh.2008.11.017.